Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells.
Bobadilla Muñoz M, Orbe J, Abizanda G, Machado FJD, Vilas A, Ullate-Agote A, Extramiana L, Baraibar Churio A, Aranguren XL, Cantero G, Sáinz Amillo N, Rodríguez JA, Ramos García L, Romero Riojas JP, Vallejo-Illarramendi A, Paradas C, López de Munain A, Páramo JA, Prósper F, Pérez-Ruiz A. Bobadilla Muñoz M, et al. Among authors: vallejo illarramendi a. Front Cell Dev Biol. 2023 May 9;11:1128534. doi: 10.3389/fcell.2023.1128534. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37228645 Free PMC article.
Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity.
Núñez-Manchón J, Capó J, Martínez-Piñeiro A, Juanola E, Pesovic J, Mosqueira-Martín L, González-Imaz K, Maestre-Mora P, Odria R, Savic-Pavicevic D, Vallejo-Illarramendi A, Mamchaoui K, Bigot A, Mouly V, Suelves M, Nogales-Gadea G. Núñez-Manchón J, et al. Among authors: vallejo illarramendi a. iScience. 2024 May 7;27(6):109930. doi: 10.1016/j.isci.2024.109930. eCollection 2024 Jun 21. iScience. 2024. PMID: 38832025 Free PMC article.
A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1.
García-Puga M, Gerenu G, Bargiela A, Espinosa-Espinosa J, Mosqueira-Martín L, Sagartzazu-Aizpurua M, Aizpurua JM, Vallejo-Illarramendi A, Artero R, López de Munain A, Matheu A. García-Puga M, et al. Among authors: vallejo illarramendi a. Cells. 2024 Nov 22;13(23):1939. doi: 10.3390/cells13231939. Cells. 2024. PMID: 39682688 Free PMC article.
Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis.
Zufiría M, Pikatza-Menoio O, Garciandia-Arcelus M, Bengoetxea X, Jiménez A, Elicegui A, Levchuk M, Arnold-García O, Ondaro J, Iruzubieta P, Rodríguez-Gómez L, Fernández-Pelayo U, Muñoz-Oreja M, Aiastui A, García-Verdugo JM, Herranz-Pérez V, Zulaica M, Poza JJ, Ruiz-Onandi R, Fernández-Torrón R, Espinal JB, Bonilla M, Lersundi A, Fernández-Eulate G, Riancho J, Vallejo-Illarramendi A, Holt IJ, Sáenz A, Malfatti E, Duguez S, Blázquez L, López de Munain A, Gerenu G, Gil-Bea F, Alonso-Martín S. Zufiría M, et al. Among authors: vallejo illarramendi a. Acta Neuropathol. 2024 Sep 16;148(1):43. doi: 10.1007/s00401-024-02794-y. Acta Neuropathol. 2024. PMID: 39283487 Free PMC article.
Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders.
Passannante R, Gómez-Vallejo V, Sagartzazu-Aizpurua M, Vignau Arsuaga L, Marco-Moreno P, Aldanondo G, Vallejo-Illarramendi A, Aguiar P, Cossío U, Martín A, Bergare J, Kingston L, Elmore CS, Morcillo MA, Ferrón P, Aizpurua JM, Llop J. Passannante R, et al. Among authors: vallejo illarramendi a. Biomedicines. 2023 Jan 18;11(2):253. doi: 10.3390/biomedicines11020253. Biomedicines. 2023. PMID: 36830793 Free PMC article.
A Ca2+-Dependent Mechanism Boosting Glycolysis and OXPHOS by Activating Aralar-Malate-Aspartate Shuttle, upon Neuronal Stimulation.
Pérez-Liébana I, Juaristi I, González-Sánchez P, González-Moreno L, Rial E, Podunavac M, Zakarian A, Molgó J, Vallejo-Illarramendi A, Mosqueira-Martín L, Lopez de Munain A, Pardo B, Satrústegui J, Del Arco A. Pérez-Liébana I, et al. Among authors: vallejo illarramendi a. J Neurosci. 2022 May 11;42(19):3879-3895. doi: 10.1523/JNEUROSCI.1463-21.2022. Epub 2022 Apr 6. J Neurosci. 2022. PMID: 35387872 Free PMC article.
Targeting the Ubiquitin-Proteasome System in Limb-Girdle Muscular Dystrophy With CAPN3 Mutations.
Lasa-Elgarresta J, Mosqueira-Martín L, González-Imaz K, Marco-Moreno P, Gerenu G, Mamchaoui K, Mouly V, López de Munain A, Vallejo-Illarramendi A. Lasa-Elgarresta J, et al. Among authors: vallejo illarramendi a. Front Cell Dev Biol. 2022 Mar 2;10:822563. doi: 10.3389/fcell.2022.822563. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35309930 Free PMC article.
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies.
Soblechero-Martín P, López-Martínez A, de la Puente-Ovejero L, Vallejo-Illarramendi A, Arechavala-Gomeza V. Soblechero-Martín P, et al. Among authors: vallejo illarramendi a. Neuropathol Appl Neurobiol. 2021 Oct;47(6):711-723. doi: 10.1111/nan.12735. Epub 2021 Jun 4. Neuropathol Appl Neurobiol. 2021. PMID: 33999469 Free PMC article.
32 results